- Home
- RLYB vs BREA Comparison
RLYB vs BREA Comparison
Compare RLYB & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- BREA
- Stock Information
- Founded
- RLYB 2018
- BREA 2022
- Country
- RLYB United States
- BREA Ireland
- Employees
- RLYB N/A
- BREA N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- RLYB Health Care
- BREA Consumer Discretionary
- Exchange
- RLYB Nasdaq
- BREA Nasdaq
- Market Cap
- RLYB 14.4M
- BREA 16.1M
- IPO Year
- RLYB 2021
- BREA 2023
- Fundamental
- Price
- RLYB $0.50
- BREA $6.31
- Analyst Decision
- RLYB Hold
- BREA
- Analyst Count
- RLYB 3
- BREA 0
- Target Price
- RLYB $15.00
- BREA N/A
- AVG Volume (30 Days)
- RLYB 8.4M
- BREA 15.9K
- Earning Date
- RLYB 08-07-2025
- BREA 01-01-0001
- Dividend Yield
- RLYB N/A
- BREA N/A
- EPS Growth
- RLYB N/A
- BREA N/A
- EPS
- RLYB N/A
- BREA N/A
- Revenue
- RLYB $848,000.00
- BREA $2,988,009.00
- Revenue This Year
- RLYB N/A
- BREA N/A
- Revenue Next Year
- RLYB N/A
- BREA N/A
- P/E Ratio
- RLYB N/A
- BREA N/A
- Revenue Growth
- RLYB N/A
- BREA 151.51
- 52 Week Low
- RLYB $0.22
- BREA $5.00
- 52 Week High
- RLYB $1.54
- BREA $19.50
- Technical
- Relative Strength Index (RSI)
- RLYB 61.32
- BREA 43.82
- Support Level
- RLYB $0.42
- BREA $6.51
- Resistance Level
- RLYB $0.54
- BREA $7.48
- Average True Range (ATR)
- RLYB 0.07
- BREA 0.65
- MACD
- RLYB 0.01
- BREA -0.07
- Stochastic Oscillator
- RLYB 56.61
- BREA 9.90
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.